Timetable
Program for Thursday, 21 February 2008
0900 - 1000: Plenary 1
Clinical Significance of Extended Spectrum Beta-lactamases
David Paterson, Queensland Health Pathology Services, Queensland
1000 - 1030: Morning Tea
1030 - 1200: Symposium 1 - ESBL/AmpC Update
Origin of the Plasmids and Transmission
David Paterson, Queensland Health Pathology Services, Queensland
Laboratory Definitions, Detection and Screening
Peter Hawkey, University of Birmingham, United Kingdom
Australian and Regional Surveillance Data - What are we Importing
John Turnidge, Women's and Children's Hospital, South Australia
1200 - 1400: Lunch and Posters
Authors in Attendance
1400 - 1530: Proffered Papers 1
Six presentations
1530 - 1600: Afternoon Tea
1600 - 1730: Symposium 2 - Antimicrobial Treatment Therapies
Start Narrow versus Broad Spectrum in the ICU
Tom Solano, Prince of Wales Hospital, New South Wales
Mono-therapy versus multi-therapy - Neutropenia
Karin Thursky, Peter MacCallum Cancer Centre, Victoria
Dual-therapy versus mono-therapy - CAP
Lindsay Grayson, Austin Hospital, Victoria
Dual-therapy versus mono-therapy (Non- Neutropenic) - Pseudomonas
David Andresen, Children's Hospital at Westmead, New South Wales
1730 - 1830: Annual General Meeting
1830 - 2000: Welcome Reception
Program for Friday, 22 February 2008
0900 - 1000: Plenary 2
Extended Spectrum Beta-lactamses: Not Just a Hospital Problem?
Peter Hawkey, University of Birmingham, United Kingdom
1000 - 1030: Morning Tea
1030 - 1200: Symposium 3 - Multi-Resistant Gram Negative Bacteria
Multiresistant Pseudomonas: Resistance Mechanisms and Epidemiology
Michael Nissen, Royal Children's Hospital, Queensland
Quinolones: Heroes and Villains for Gram Negative Resistance
David Hooper, Massachusetts General Hosptal, United States of America
Laboratory Aspects of Carbapenem Resistance
Jan Bell, Women's and Children's Hospital, South Australia
1200 - 1400: Lunch and Posters
1400 - 1530: Proffered Papers 2
Six presentations
1530 - 1600: Afternoon Tea
1600 - 1730: Symposium 4 - W(h)ither Glycopeptides
Are there Better Drugs Available Now?
David Looke, Princess Alexandra Hospital, Queensland
Are there Better Drugs Coming?
George Kotsiou, Royal North Shore Hospital, New South Wales
Pharmacodynamics - Monitoring
John Turnidge, Women's and Children's Hospital, South Australia
1900 - 2300: Conference Dinner
Program for Saturday, 23 February 2008
0900 - 1000: Plenary 3
Efflux Pumps and Nosocomial Antibiotic Resistance
David Hooper, Massachusetts General Hosptal, United States of America
1000 - 1030: Morning Tea
1030 - 1200: Symposium 5 - Fungal Therapy
Diagnosis - Study Report
Orla Morrissey, The Alfred Hospital, Victoria
Azole Prophylaxis - Pros and Cons
Sam Milliken, St Vincent's Hospital Sydney, New South Wales
Empirical Pre-emptive Treatment - When to Start, What With, In Excess?
Chris Blyth, Royal North Shore Hospital, New South Wales
1200 - 1300: Lunch
1300 - 1430: Proffered Papers 3
Six presentations
1430 - 1500: Afternoon Tea
1500 - 1700: Workshop 1: Fungal Susceptibility Workshop
Coordinator
David Ellis, Women's and Children's Hospital, South Australia
Antifungal Susceptibility Testing and Resistance Trends - CLSI
David Ellis, Women's and Children's Hospital, South Australia
Antifungal Susceptibility Testing - MRS
Tania Sorrell, Westmead Hospital, New South Wales
Antifungal Resistance Mechanisms
Sharon Chen, Westmead Hospital, New South Wales
Antifungal Drug Levels
Debbie Marriott, St Vincents Hospital, New South Wales
The Utility of Galactomannan Testing for the Rapid Diagnosis of Aspergillosis
Catriona Halliday, Westmead Hospital, New South Wales
1300 - 1700: Workshop 2: Pharmacy Workshop
Coordinator
David Kong, Monash University, Victoria
Session 1: Antibiotics Stewardship - No Longer the Drug Police (1300 - 1500)
Antibiotic Stewardship - An Overseas and ID Clinician's Perspective
David Paterson, Queensland Health Pathology Services, Queensland
Giving Life to Antibiotic Stewardship - Metropolitan Perspective
Matthew Rawlins, Royal Perth Hospital, Western Australia
Bridging the Gap - Antibiotic Stewardship from Regional to Metropolitan
Rachel Taylor, Port Macquarie Base Hospital, New South Wales
1500 - 1530: Afternoon Tea
Session 2: The Bugs and Drugs (1530 -1700)
Microbiology Today and Twenty Years Ago
Elaine Cheong, Concord Hospital, New South Wales
Continuous Antimicrobial Infusions in Ambulatory Setting
John Turnidge, Women's and Children's Hospital, South Australia
Managing Antifungals in Immunocompromised Patients - Case Studies
Verna Wallroth, Peter MacCallum Centre, Victoria and Lisa Ho, Austin Hospital, Victoria
Disclaimer
This program is correct at the time of printing, but organisers reserve the right to alter the program as deemed necessary.